throbber
Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 1 of 138
`
` Pages 1 - 137
`
`UNITED STATES DISTRICT COURT
`
`NORTHERN DISTRICT OF CALIFORNIA
`
`BEFORE THE HONORABLE WILLIAM H. ALSUP, JUDGE
`
`FINJAN, INC., )
` )
` Plaintiff, )
` )
` VS. ) NO. C 17-5659 WHA
` )
`JUNIPER NETWORKS, INC., )
` ) San Francisco, California
` Defendant. )
` )
`___________________________________)
`
` Tuesday, December 4, 2018
`
`TRANSCRIPT OF PROCEEDINGS
`
`APPEARANCES:
`
`For Plaintiff:
` KRAMER LEVIN NAFTALIS & FRANKEL, LLP
` 990 Marsh Road
` Menlo Park, California 94025
` BY: PAUL ANDRE, ESQ.
` LISA KOBIALKA, ESQ.
` AUSTIN MANES, ESQ.
` YURIDIA CAIRE, ESQ.
` KRISTOPHER B. KASTENS, ESQ.
`
`For Defendant:
`
` IRELL & MANELLA, LLP
` 840 Newport Center Drive
` Suite 400
` Newport Beach, California 92660
` BY: REBECCA L. CARSON, ESQ.
` KEVIN X. WANG, ESQ.
`
`Reported By: BELLE BALL, CSR 8785, CRR, RDR
` Official Reporter, U.S. District Court
`
`(Appearances continued, next page)
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 2 of 138
`
`APPEARANCES, CONTINUED:
`
`For Defendant:
` IRELL & MANELLA, LLP
` 1800 Avenue of the Stars
` Suite 900
` Los Angeles, California 90024
` BY: JONATHAN S. KAGAN, ESQ.
` CASEY M. CURRAN, ESQ.
` ALAN HEINRICH, ESQ.
` SHARON SONG, ESQ.
` JOSHUA GLUCOFT, ESQ.
`
`Also Present: JULIE ANN MAR-SPINOLA
` ANN TAYLOR
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 3 of 138
`
` 3
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Tuesday - December 4, 2018
`
` 9:02 a.m.
`
`P R O C E E D I N G S
`
`THE CLERK: Calling Civil Action, 17-5659, Finjan
`
`Inc. versus Juniper Networks, Inc.
`
`Counsel, please step forward and state your appearances
`
`for the record.
`
`THE COURT: Good morning.
`
`MR. ANDRE: Good morning, Your Honor. Paul Andre for
`
`Finjan. And I have my client representatives here today,
`
`Julie Mar-Spinola and Ann Taylor in the back (Indicating).
`
`And with me -- they're back there (Indicating).
`
`THE COURT: Okay. Welcome to all of you.
`
`MR. ANDRE: And I would introduce the attorneys, if
`
`that's okay.
`
`THE COURT: Sure.
`
`MR. ANDRE: Kristopher Kastens, Austin Manes, Lisa
`
`Kobialka and Cristina Martinez.
`
`THE COURT: Thank you.
`
`Welcome to all of you.
`
`MR. ANDRE: Thank you, Your Honor.
`
`MR. KAGAN: Good morning, Your Honor. Jonathan Kagan
`
`of Irell & Manella for Juniper Networks. And with me are
`
`Rebecca Carson --
`
`MS. CARSON: Good morning.
`
`THE COURT: Alan Heinrich.
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 4 of 138
`
` 4
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. HEINRICH: Good morning.
`
`MR. KAGAN: Kevin Wang, Casey Curran, Sharon Song and
`
`Josh Glucoft.
`
`THE COURT: Welcome to all of you.
`
`MR. KAGAN: Thank you, Your Honor.
`
`THE COURT: We are here for a final pretrial
`
`conference for a trial that starts on Monday. And, just jump
`
`right in.
`
`So we have a jury selection process -- ready?
`
`MR. KAGAN: Your Honor, there's one issue we thought
`
`we might raise as a preliminary matter with your -- it relates
`
`to a filing that Finjan made last night.
`
`THE COURT: I haven't seen it.
`
`MR. KAGAN: So --
`
`THE COURT: Did we look? I thought we looked.
`
`THE LAW CLERK: Yeah.
`
`THE COURT: Was there any filing?
`
`THE LAW CLERK: Witness lists, exhibits --
`
`THE COURT: I didn't see, I don't know anything about
`
`it. So what is the issue?
`
`MR. KAGAN: So the issue is we understood from the
`
`Court's ruling yesterday that plaintiffs' damages expert
`
`Mr. Arst would be excluded, based on the Daubert ruling.
`
`And we received -- and we thought the process would then
`
`be the parties would try to streamline their witness list to
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 5 of 138
`
` 5
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`remove witnesses that were no longer necessary in order to
`
`relate to Mr. Arst's testimony and his theory.
`
`But when we got the amended witness list from Finjan, it
`
`included Mr. Arst again, notwithstanding that the Court had
`
`excluded all of his testimony.
`
`And so we'd asked -- I asked last night when we received
`
`this: What portions of Mr. Arst's testimony do you think
`
`survive?
`
`I never got a response from Finjan on that. They simply
`
`filed the list.
`
`So I guess the -- as a preliminary, as a preliminary
`
`matter maybe we should take up that because I think it would
`
`affect the scope of the case. But also, we would certainly at
`
`this point, given the positions they have taken and the fact
`
`they refuse to disclose to us what they intend to put on as a
`
`damages case, we request a formal offer of proof on what their
`
`damages case will look like, in light of this Court's Daubert
`
`order.
`
`THE COURT: All right. That's your position.
`
`What do you have to say, Mister --
`
`MR. ANDRE: Your Honor, we amended the witness list
`
`based on a deposition we took of Mr. Icasiano, a defendant
`
`witness that was disclosed light and subject to these MILs.
`
`And we amended it conditionally that if he's not excluded,
`
`that we designate his deposition and the exhibits that were
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 6 of 138
`
` 6
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`used in his deposition, which was just taken last week. We
`
`just got the transcript in.
`
`So we amended the witness list before the pretrial
`
`conference --
`
`THE COURT: Can somebody hand this thing up to me?
`
`My law clerk didn't give it to me.
`
`Did you give it to me? I don't remember seeing this.
`
`THE LAW CLERK: (Inaudible)
`
`MR. KAGAN: Your Honor, with regard to the issue of
`
`Mr. Icasiano, given the Court's Daubert order, we agreed to
`
`withdraw him. This is a moot issue. He was relevant only to
`
`rebut the damages theory that has now been excluded.
`
`(Document handed up to the Court)
`
`MR. KAGAN: And we informed Finjan of this as well.
`
`There is a motion in limine to exclude Mr. Icasiano's
`
`testimony. In light of the Daubert, we -- there's no reason
`
`to oppose it. We're withdrawing him.
`
`(Reporter interruption)
`
`THE COURT: I don't even see his name on this list.
`
`MR. ANDRE: It should be at the bottom, Your Honor.
`
`By deposition only.
`
`THE COURT: It says Philip Hartstein.
`
`MR. ANDRE: Probably on the back. It's probably
`
`two-sided, Your Honor.
`
`THE COURT: Oh, I see.
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 7 of 138
`
` 7
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. ANDRE: I'm sorry.
`
`(The Court examines document)
`
`THE COURT: Well, the -- the Court's Daubert order
`
`did exclude Arst. So --
`
`MR. ANDRE: Your Honor, with respect to Mr. Arst, you
`
`his cost savings opinion. We would still like to offer him
`
`into testimony to provide issues he did not address like the
`
`Georgia-Pacific factors. He can give him the jury a framework
`
`that they can use to determine a reasonable royalty.
`
`So it -- it's not uncommon to have an expert get up and
`
`not give an opinion as to what damages will be, but to give the
`
`jury a framework they can use to determine a reasonable
`
`royalty.
`
`So we would still propose that Mr. Arst would testify to
`
`that limited extent, you didn't address it in your Daubert, you
`
`said that his cost savings model where he gave a 60- to $70
`
`million figure was unreliable due to the size of it, based on
`
`the revenues. But the rest of his opinion, which he goes and
`
`talks about how one decides a reasonable royalty, for example,
`
`hypothetical negotiation, where the parties are sitting, all
`
`that kind of stuff, I think that's still in the case. You
`
`didn't address that. And I think that would be beneficial to
`
`the jury to get that framework in our case-in-chief. But he
`
`would not give the opinion.
`
`THE COURT: What do you say on that?
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 8 of 138
`
` 8
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. KAGAN: Well, to the extent you're talking about
`
`the framework, that's got to be a subject for jury
`
`instructions. You don't need the expert to come in and
`
`explain what the framework is.
`
`What -- what they're trying do now is to use Mr. Arst to
`
`give essentially not the framework, but their opinion on how
`
`the framework should be implemented. And on that point, we'd
`
`just like to know that in Mr. Arst's opinion, he essentially
`
`said the hypothetical framework doesn't make sense, which is
`
`why he chose his cost approach. So this was a framework that
`
`he essentially injected.
`
`So for example, in his report, he said (As read):
`
`"Finjan's historical licensing practices were derived
`
`from historical jury verdicts, and they have no
`
`reason to assume or conclude that would apply to
`
`Juniper in this case."
`
`And there's numerous examples of this throughout his
`
`report. So what he did was the very framework that they now
`
`want to introduce through Mr. Arst is exactly what he rejected
`
`in his report in favor of this cost statements analysis.
`
`And I would suggest that that is simply not right. They
`
`took their chance with Mr. Arst. They chose not to have him
`
`apply a traditional royalty analysis and instead, they want to
`
`swing for the fences but they struck out. They don't get to
`
`come back now and say: Okay, now let's let him bring up this
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 9 of 138
`
` 9
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`other theory that he never really introduced. And there's
`
`nothing in Court's order that would support that. His
`
`testimony is excluded. He is considered to be an unreliable
`
`expert.
`
`MR. ANDRE: May I address that, Your Honor?
`
`THE COURT: Sure.
`
`MR. ANDRE: Okay. I disagree. He's not an
`
`unreliable expert. His opinion as to the cost savings was
`
`unreliable (sic). His qualifications as an expert are
`
`impeccable. As far as the Georgia-Pacific analysis, he
`
`actually has several pages in his report, starting on Page 45,
`
`where he goes through each one of the Georgia-Pacific factors,
`
`and just says this is a framework --
`
`THE COURT: Give me the paragraph numbers in his
`
`report that you believe are not affected by the Court's
`
`Daubert order, and that you still think could -- may be
`
`coherent testimony before the jury. Give it to me by
`
`paragraph number.
`
`MR. ANDRE: Your Honor, unfortunately they're not
`
`numbered paragraphs or pages. And they have section numbers.
`
`I can give that to you, that's acceptable.
`
`THE COURT: All right. Give it to me in that format.
`
`MR. ANDRE: Okay. So first is Page 4, Section 6.1,
`
`where he talks about Finjan and who they are, and how they
`
`handle their negotiations. 6.1.1 on Page 7, it's Finjan's
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 10 of 138
`
` 10
`
`licensed technology.
`
`THE COURT: I'm sorry. Wait, wait. I've got Page 4,
`
`6.1. Then what?
`
`MR. ANDRE: Page 7, 6.1.1.
`
`THE COURT: All right.
`
`MR. ANDRE: And then Page 12, 6.1.2.
`
`THE COURT: Okay, then what?
`
`MR. ANDRE: Then Page 15, 6.1.3.
`
`(Off-the-Record discussion between counsel)
`
`MR. ANDRE: Page 18, 6.2. Page 19, 6.3 and 6.3.1.
`
`(Off-the-Record discussion)
`
`MR. ANDRE: Page 27, 6.4.
`
`THE COURT: Does 6.3.1 go all the way to 27?
`
`MR. ANDRE: No. I think there's a section there that
`
`would probably be very close to what you excluded. There's
`
`overlaps, so I don't want to run the risk of overlapping
`
`anywhere.
`
`So 6.3.1 ends on Page --
`
`THE COURT: All right. So just -- I'm going to
`
`just -- the section numbers are the key parts. All right.
`
`MR. ANDRE: Yeah.
`
`THE COURT: And then what else?
`
`MR. ANDRE: 6.4, which is the timeline of events. In
`
`Section 7 he talks about the reasonable royalty damages.
`
`THE COURT: Wait a minute. What goes there?
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 11 of 138
`
` 11
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MR. ANDRE: Page 27, Section 7.
`
`(Off-the-Record discussion between counsel)
`
`MR. ANDRE: He talks about the statute of the
`
`reasonable royalty. And the hypothetical negotiation, the
`
`framework.
`
`THE COURT: I'm not saying yes yet, but tell me what
`
`you think can be salvaged.
`
`MR. ANDRE: Section 29, 7.1, the date of the parties
`
`to the hypothetical negotiation. Section 7.2 on Page 29, and
`
`7.3 on Page 30.
`
`Excluded several of this stuff. And then you get to
`
`Georgia-Pacific factors. First of all, the -- the income
`
`approach on 7.3.3 on Page 44.
`
`THE COURT: 7.3.3?
`
`MR. ANDRE: Uh-huh.
`
`THE COURT: On Page 34?
`
`MR. ANDRE: Page 44. And on Page 45, Section 7.5,
`
`that's the Georgia-Pacific analysis, and that goes for several
`
`pages, up to Page 52.
`
`THE COURT: Is that it?
`
`MR. ANDRE: That's it, Your Honor.
`
`THE COURT: So I don't have an answer for you on
`
`this.
`
`What does the other side say?
`
`MR. KAGAN: So there are two points, Your Honor. The
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 12 of 138
`
` 12
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`first is that although Mr. Arst did mention the
`
`Georgia-Pacific factors in his opinion, he said that they had
`
`zero influence or neutral influence on his opinion.
`
`Specifically, if you look in Section 7.5, which is where
`
`he discusses the Georgia-Pacific analysis, he says (As read):
`
`"In determining a reasonable royalty for Juniper's
`
`alleged use of the '494 patent, I've undertaken an
`
`assessment of the 15 factors set forth in the
`
`Georgia-Pacific case."
`
`He then says -- I'm going skip -- he says:
`
`"For this reason, the Georgia-Pacific factors are
`
`frequently used by my peers who evaluate damages in
`
`the context of commercial litigation. However, it is
`
`important to bear in mind that the relative weight
`
`and importance of the factors can and do vary from
`
`case to case."
`
`And he then stated, towards the end that section:
`
`"As I previously discussed, I've concluded that the
`
`cost approach provides the best available indicator
`
`of the economic footprint of the '494 patent for
`
`purposes of evaluating the hypothetical negotiation
`
`in this case."
`
`THE COURT: But where does he say he rejects the
`
`Georgia-Pacific factors?
`
`MR. KAGAN: He doesn't. What he says is that they
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 13 of 138
`
` 13
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`would have a neutral impact on this, on his analysis.
`
`THE COURT: What would?
`
`MR. KAGAN: The Georgia-Pacific factors. So in other
`
`words, he has his cost approach. And he says: I've looked at
`
`the Georgia-Pacific factors, but they don't affect my
`
`analysis.
`
`So, he has his cost approach. And he says the
`
`Georgia-Pacific factors neither raise it nor lower it, so they
`
`have zero impact on his opinion. That's what he says.
`
`The second point which I think is dispositive as well is
`
`that in none of the sections of Mr. Arst's report that they
`
`have cited, and they want to include, does Mr. Arst do an
`
`apportionment of damages.
`
`And this is important because, as I think -- I think Mr.
`
`Andre, himself, personally argued the Blue Coat case on behalf
`
`of Finjan, where the Federal Circuit actually injected a -- a
`
`damages award where Finjan had failed to show apportionment of
`
`the damage.
`
`And this means when you have a product where all of the
`
`value is not derived from the patented invention -- now, that
`
`would obviously include the products in this case -- it is the
`
`plaintiff's burden to apportion and to say: This is the
`
`incremental value that is caused by the patent. Versus: This
`
`is the rest of the value that is attributable to other factors.
`
`Juniper's patents, other intellectual property, brand name,
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 14 of 138
`
` 14
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`et cetera.
`
`There's nothing in the cited sections of Mr. Arst's report
`
`that addresses the apportionment issue. And if Finjan cannot
`
`present apportionment testimony, they cannot present a damages
`
`case. Their damages case fails, as a matter of law.
`
`And assuming, given Mr. Andre's familiarity with the Blue
`
`Coat case, I don't think he would dispute that principle of
`
`law.
`
`THE COURT: "Blue" what?
`
`MR. KAGAN: Finjan versus Blue Coat.
`
`THE COURT: "Coat," like --
`
`MS. CARSON: C-O-A-T. Like a jacket (Indicating).
`
`THE COURT: Blue Coat. That says you have to
`
`apportion?
`
`MR. KAGAN: That, among other cases. It's applying
`
`another set of cases.
`
`But, you know, given the closeness and the familiarity of
`
`the counsel in this case with the Blue Coat case, I think it's
`
`-- it's very apt. And specifically, I can read a couple
`
`portions of the case if the Court --
`
`THE COURT: No, I understand the apportionment
`
`concept. But, look, did -- all right. We've had enough on
`
`this. I'm not going to make a ruling now.
`
`I may or may not allow Arst to testify. We will see. We
`
`have a trial coming on Monday. We're going to get ready for
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 15 of 138
`
` 15
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`it.
`
`You do have a problem. It is true, you swung for the
`
`fences and struck out. So that was the gamble you took. If
`
`you had won the gamble, it would have been a home run, maybe
`
`the World Series. But, God bless you for trying, but it was
`
`like Babe Ruth sometimes did hit a home run. He had more
`
`strikeouts than anybody at the time. But he also had a lot of
`
`home runs. This time you got a strikeout, at least in the
`
`District Court.
`
`But I am not prepared to say that -- you know, you
`
`big-firm people think that you've got to have an expert or you
`
`don't get damages. It's not quite true. You can present a
`
`damages case sometimes without an expert. It happens all the
`
`time in other kinds of cases.
`
`Is there a Federal Court -- a Federal Circuit decision
`
`somewhere that says if you don't have an expert, you get no
`
`damages? I doubt it.
`
`MR. KAGAN: There is not.
`
`MR. ANDRE: Just the opposite, Your Honor.
`
`THE COURT: So I feel like maybe Mr. Andre --
`
`sometimes -- Babe Ruth could come up again. Maybe he gets --
`
`get a second bite at the apple during the trial. Maybe he can
`
`ambush your guy. What's your guy's name? Rubin?
`
`MR. KAGAN: Ugone.
`
`THE COURT: Yeah. That guy. Maybe he will
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 16 of 138
`
` 16
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`cross-examine him so skillfully that the jury will award
`
`$70 million.
`
`MR. KAGAN: Your Honor, given that they're stuck with
`
`a $1.8 million base, I think that's unlikely.
`
`THE COURT: Yeah, I think so, too. But I'm -- that's
`
`why I enjoy this. Because he's going to get maybe a shot,
`
`shot to try.
`
`MR. KAGAN: Your Honor --
`
`THE COURT: No, I'm not going to be talked out of
`
`this. You're not going to just get to the end of the case
`
`because I exclude their expert. There's other ways to prove
`
`damages. And I'm not prepared to say he doesn't have a
`
`damages case at all.
`
`MR. KAGAN: I wasn't going to argue that. What I was
`
`going to ask, though, is if we could get a formal offer of
`
`proof --
`
`THE COURT: He has. He went through each section
`
`that he wants to prove.
`
`That's the offer of proof, right?
`
`MR. ANDRE: Your Honor, it is for Mr. Arst. That's
`
`what he will testify to. And Your Honor is absolutely
`
`correct. We will put on a fact-based case.
`
`I've tried several cases the last two days without a
`
`damages expert.
`
`THE COURT: That's good. Actually, it heartens me to
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 17 of 138
`
` 17
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`hear that. Because these experts are all bought and paid for.
`
`You don't have to admit it, but they are. And it's good to
`
`know that some lawyer, somewhere, can still try a case without
`
`an expert.
`
`MR. ANDRE: We've done it several times, Your Honor.
`
`And I personally prefer it. I know some courts don't like it,
`
`but I think it's the way we should do it in the future because
`
`I think these experts are --
`
`THE COURT: Bought and paid for. You don't have to
`
`say it.
`
`MR. ANDRE: Well, I won't say that, but --
`
`THE COURT: Okay. That's all I'm going to say on
`
`this subject for now. I may -- I've got to look at these
`
`sections and see if I think there is something coherent there,
`
`that, that the jury ought to -- so if you're going to put
`
`anything -- how many lawyers you got there? One, two, three
`
`four, five, six, seven lawyers at that table.
`
`So by 5:00 today, if you have anything to say on these
`
`subjects, these sections, it's due by 5:00 p.m. So one of
`
`those lawyers -- five of them, seven -- better get cracking if
`
`you want to explain why this is not a coherent thing.
`
`Okay. Now we have some other motions in limine that I
`
`want to take up. Let's start with the ones that are directed
`
`at the plaintiff's case.
`
`So Motion No. 1 to exclude evidence regarding Cyphort and
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 18 of 138
`
` 18
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the ATP appliance product.
`
`So first let me ask Finjan to explain the relevance of
`
`whatever that testimony is, and then I'll get the other side to
`
`explain why it should be excluded.
`
`So give me your offer of proof on those subjects, and then
`
`why you think it's relevant. Go ahead.
`
`MS. KOBIALKA: So first and foremost, it's relevant
`
`because it goes to the issue of damages, and in particular,
`
`notice. Cyphort received specific notice regarding the '494
`
`patent which is at issue here, for the same class of products
`
`that we're talking about here. This is this ATP class of
`
`products. That knowledge is imputed to Juniper, who later
`
`then -- who acquired Cyphort.
`
`So first and foremost is it relates to the fact that they
`
`can't say -- and this is a disputed issue -- that they didn't
`
`know about the '494 patent, they were not aware that there were
`
`infringement allegations --
`
`THE COURT: Why do you say -- why would knowledge by
`
`Cyphort put Juniper on notice?
`
`MS. KOBIALKA: Because Juniper acquired Cyphort, and
`
`so that knowledge is imputed to Juniper.
`
`THE COURT: And when, when did that acquisition
`
`occur?
`
`MS. KOBIALKA: I believe it occurred in 2017.
`
`THE COURT: After the patent expired.
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 19 of 138
`
` 19
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MS. KOBIALKA: That may be correct. That's correct.
`
`THE COURT: So you're saying that knowledge that was
`
`acquired after the patent expired can retroactively constitute
`
`notice for purposes of the marking statute?
`
`MS. KOBIALKA: Well, for purposes of the due
`
`diligence. The closing of the deal -- I mean, it takes a long
`
`time for these type of acquisitions to occur. And my
`
`understanding, the closing of the deal was after the patent
`
`expired. But the notification process had happened around the
`
`time that Juniper was actually doing the due diligence of
`
`Cyphort. So --
`
`THE COURT: So your theory is somebody going in there
`
`do due diligence to decide whether to buy Cyphort and seeing a
`
`letter in there from Finjan saying: You infringed the '494
`
`patent would have put the acquiring company on notice, even
`
`before the acquisition, that maybe the acquiring company's own
`
`product --
`
`MS. KOBIALKA: Well, this is in addition to the
`
`notice that we also provided to Juniper. So I'm not saying
`
`that fact, in and of itself. There is -- you know, this is a
`
`fact issue. Actual notice is a factual dispute that the jury
`
`can decide. And so this is part of that notice that was
`
`provided.
`
`There was additional conversations, direct conversations
`
`which were recorded --
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 20 of 138
`
` 20
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: What does the notice have to be? Under
`
`the statute, what does the law from the Federal Circuit say
`
`that the notice has to be?
`
`MS. KOBIALKA: There has to be an affirmative
`
`representation that -- of: This particular patent's infringed
`
`by the accused. And generally, it will require some
`
`identification of the technology at issue. So the
`
`functionality would be sufficient. If you identify the
`
`functionality --
`
`THE COURT: So then don't have you to have a letter
`
`from Finjan directly to Juniper saying: Your thing infringes?
`
`MS. KOBIALKA: Absolutely not.
`
`THE COURT: Say it again, then. I misunderstood what
`
`the statute requires.
`
`MS. KOBIALKA: So the statute just requires -- and
`
`the interpretations, the Berkheimer cases, from the Federal
`
`Circuit -- is just some affirmative representation. That can
`
`be by oral notice. It is not required to be written.
`
`There are other portions of the statute, for example, when
`
`you're dealing with a foreign entity under 271(g), where you
`
`are required written notice. But most instances, there is
`
`written notice. And that's why a lot of the cases talk about
`
`written notice.
`
`However, actual notice goes not require a writing. It can
`
`come in many different forms --
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 21 of 138
`
` 21
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: Actual notice of what, though?
`
`MS. KOBIALKA: Oh. Of the infringement of the
`
`patent.
`
`THE COURT: So it's not enough to know the patent
`
`exists. It has to be that your side thinks that it --
`
`accuses. Is that it?
`
`MS. KOBIALKA: Absolutely. So --
`
`THE COURT: But you don't have such a letter. You
`
`don't even have such a conversation, do you?
`
`MS. KOBIALKA: Yes, we do.
`
`THE COURT: What is your conversation?
`
`MS. KOBIALKA: The conversation took -- well, there
`
`was first notification about licensing the portfolio,
`
`February 9, 2017. The '494 patent wasn't specifically
`
`identified there.
`
`THE COURT: Was? Or was not?
`
`MS. KOBIALKA: Was not.
`
`THE COURT: Okay.
`
`MS. KOBIALKA: However, subsequently, there were
`
`discussions between John Garland who works for Finjan, and
`
`Scott Coonan, who works for Juniper, who is, I believe, their
`
`head of IP. And Mr. Coonan recorded these phone calls.
`
`In all the deposition testimony -- and I can quote that --
`
`the '494 was specifically identified. This class of products
`
`that ATP class of products, whether it's a box or if it's in
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 22 of 138
`
` 22
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the cloud, was identified as infringing.
`
`And Mr. Garland --
`
`THE COURT: And this was in a phone call?
`
`MS. KOBIALKA: That was -- yes.
`
`THE COURT: Recorded.
`
`MS. KOBIALKA: It turns out Mr. Coonan recorded it,
`
`unbeknownst to us.
`
`THE COURT: So when we hear the recording it will say
`
`something like -- this is one that you want to exclude, I
`
`think.
`
`MS. KOBIALKA: (Nods head)
`
`THE COURT: But if the jury hears it, it would say
`
`something like: Oh, the '494. Oh, your ATP system infringes
`
`it.
`
`MS. KOBIALKA: Yeah. We think you need a license to
`
`the '494 patent in addition to these other ones.
`
`And in particular, the types of technologies that were at
`
`issue that they were talking about in that conversation.
`
`THE COURT: All right. So the statute -- you say
`
`that would be -- that, alone, would be enough to provide
`
`notice.
`
`When did that conversation occur?
`
`MS. KOBIALKA: November, 2015.
`
`THE COURT: And what is our damages period here?
`
`MS. KOBIALKA: It ends January 29, 2017.
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 23 of 138
`
` 23
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THE COURT: And when does it begin.
`
`MS. KOBIALKA: Issued in 2014. I think March, 2014.
`
`THE COURT: What issue?
`
`MS. KOBIALKA: The patent at issue. The '494 patent.
`
`THE COURT: Okay. How come it's such a short patent?
`
`MS. KOBIALKA: This particular patent -- oh, the
`
`priority goes way back. It is a continuation of some earlier
`
`patent.
`
`THE COURT: Okay.
`
`MS. KOBIALKA: And I think there was a number of
`
`challenges to it over time, but it withstood all those
`
`changes.
`
`THE COURT: All right. 2014 to when, 2017?
`
`MS. KOBIALKA: I have the exact date. March 18, 2014
`
`through January -- I believe it's 29, 2017.
`
`THE COURT: And that's the damages period.
`
`MS. KOBIALKA: Yes.
`
`THE COURT: And when did this phone call take place?
`
`MS. KOBIALKA: November, 2015.
`
`THE COURT: All right. So, let's just pause right
`
`there for a second.
`
`I want to hear from the other side on the phone call, and
`
`why that would not have been enough notice, and what does the
`
`statute require for notice and so forth.
`
`Go ahead.
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 24 of 138
`
` 24
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MS. CARSON: Well, Your Honor, the Federal Circuit
`
`has found that what is required for the notice is that there's
`
`an affirmative communication to the alleged infringer of a
`
`specific charge of infringement by a specific accused product
`
`or device.
`
`So Finjan is trying to broaden this requirement or to
`
`loosen this requirement to not require the identification of a
`
`specific accused product or device.
`
`Whether in oral or written notice, Finjan never identified
`
`Sky ATP or SRX used in combination with Sky ATP.
`
`THE COURT: I'm sorry; your name, again, is what?
`
`MS. KOBIALKA: Kobialka. Lisa Kobialka.
`
`THE COURT: Can -- do I have a list? Is this --
`
`where's my list?
`
`(Off-the-Record discussion between the Court and Clerk)
`
`THE COURT: Oh, here we go. "Kobialki."
`
`MS. KOBIALKA: Kobialka. Yes.
`
`THE COURT: And your name over there is --
`
`MS. CARSON: Ms. Carson.
`
`THE COURT: Sorry, I just don't see -- would you
`
`highlight it on here? I can't find the names on there.
`
`(Document handed down)
`
`THE COURT: Okay. There's so much information, I
`
`can't find what I need.
`
`All right. So, Ms. K -- K-o-b, and I'll get it right in a
`
`

`

`Case 3:17-cv-05659-WHA Document 300 Filed 12/06/18 Page 25 of 138
`
` 25
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`minute; I apologize -- says you don't need to have what you
`
`just told me. That you're -- you're amplifying on what's
`
`required. She said that the telephone call identified your
`
`product, said you needed a license.
`
`What, what am I missing?
`
`MS. CARSON: Well, Your Honor, I think she is not
`
`accurately describing what occurred during the phone call.
`
`Mr. Gardner never specifically identified Sky ATP. The only
`
`product that he specifically mentioned was the SRX.
`
`And they have not ac

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket